Safety and Efficacy of Boceprevir in Asia Pacific Participants With Chronic Hepatitis C Genotype 1 (P07063)

Clinical trial NCT01390844 · COMPLETED

Trial details

NCT number: NCT01390844
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis C, Chronic

Start date: 2011-10-21
Primary completion: 2015-06-19
Enrollment: 282

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.